"The Effect Of Subcutaneous Epinephrine Dosage On Blood Loss In Surgical Incision"
To Determine the Optimal Doses of Adrenaline in Preventing Blood Loos in Participants Undergoing Supraclavicular Flap Surgery
About this trial
This is an interventional prevention trial for To Determine the Optimal Doses of Adrenaline in Preventing Blood Loos in Participants Undergoing Supraclavicular Flap Surgery focused on measuring Plastic reconstructive surgery, blood loss, epinephrine, supraclavicular flap
Eligibility Criteria
Inclusion Criteria: Age≥ 18 years Patients who are undergoing supraclavicular flap surgery Patients wishing to be a part of study. Either gender Exclusion Criteria: • Participants with cardio vascular diseases. Participants with collagen vascular diseases Participant who are on non-steroidal anti-inflammatory drugs, anticoagulants, or aspirin. .
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Placebo Comparator
Epinephrine 1:200,000
Epinephrine 1:400,000
Placebo
In this group participants will receive the epinephrine concentration of 1:200,000 in normal saline
In this group participants will receive the epinephrine concentration of 1:400,000 in normal saline
In this group participants will receive only 10 ml of normal saline (control group)